• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma


41.6500 USD 0.4500 1.07%

As of 20:10:00 ET on 08/20/2014.

Snapshot for Eisai Co Ltd (ESALF)

Open: 41.6500 Day's Range: 41.6500 - 41.6500 Volume: 240
Previous Close: 42.1000 52wk Range: 36.8000 - 42.4000 1-Yr Rtn: +7.51%

Stock Chart for ESALF

No chart data available.
  • ESALF:US 41.6500
  • 1D
  • 1M
  • 1Y
Interactive ESALF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESALF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 37.8173
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 114.5070
Est. PEG Ratio 4.1833
Market Cap (M USD) 12,352.01
Shares Outstanding (M) 296.57
30 Day Average Volume 16
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.46%
Cash Dividend (JPY) 70.0000
Dividend Ex-Date 09/26/2014
5 Year Dividend Growth 1.74%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESALF

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ESALF

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Haruo NaitoPresident/CEOHideki HayashiDeputy President
Yutaka TsuchiyaDeputy PresidentHajime ShimizuDeputy President
More Company Profile & Key Executives for ESALF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil